Cover Image

Gefitinib loaded nanostructured lipid carriers: characterization, evaluation and anti-human colon cancer activity in vitro

NLC containing Gefitinib (NANOGEF) was prepared using stearic acid, sesame oil and surfactants (sodium lauryl sulfate and tween 80). NANOGEFs were evaluated for particle size, polydispersity index (PdI), zeta potential, entrapment efficiency (EE), stability, release studies and cytotoxicity studies...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hafiz A. Makeen (Author), Syam Mohan (Author), Mohamed Ahmed Al-Kasim (Author), Ibraheem M. Attafi (Author), Rayan A. Ahmed (Author), Nabeel Kashan Syed (Author), Muhammad Hadi Sultan (Author), Mohammed Al-Bratty (Author), Hassan A. Alhazmi (Author), Mohammed M. Safhi (Author), Raisuddin Ali (Author), M. Intakhab Alam (Author)
Format:	Book
Published:	Taylor & Francis Group, 2020-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preparation, Characterization, and Anti-Cancer Activity of Nanostructured Lipid Carriers Containing Imatinib
by: Hafiz A. Makeen, et al.
Published: (2021)

Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
by: Mohammed Elmowafy, et al.
Published: (2017)

Recent Advancements in the Diagnosis, Prevention, and Prospective Drug Therapy of COVID-19
by: Waquar Ahsan, et al.
Published: (2020)

Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
by: Mohammed Elmowafy, et al.
Published: (2021)

Synthesis of some novel pyrimidine, thiophene, coumarin, pyridine and pyrrole derivatives and their biological evaluation as analgesic, antipyretic and anti-inflammatory agents
by: Karam Ahmed El-Sharkawy, et al.
Published: (2019)

Dissolution enhancement of Gefitinib by solid dispersion and complexation with β-cyclodextrins: In vitro testing, cytotoxic activity, and tablet formulation
by: Adel F. Alghaith, et al.
Published: (2024)

Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways
by: Abdullah F. AlAsmari, et al.
Published: (2020)

Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer
by: Ahmed A. El-Shenawy, et al.
Published: (2023)

Analysis of amphetamine and methamphetamine contents in seized tablets from Jazan, Saudi Arabia by liquid chromatography-mass spectroscopy (LC-MS/MS) and chemometric techniques
by: Hassan A. Alhazmi, et al.
Published: (2020)

Gefitinib-loaded starch nanoparticles for battling lung cancer: Optimization by full factorial design and in vitro cytotoxicity evaluation
by: Haitham Amin, et al.
Published: (2023)

Pharmacological melioration by Selenium on the toxicity of tellurium in neuroendocrine centre (Pituitary Gland) in male wistar rats: A mechanistic approach
by: Gulrana Khuwaja, et al.
Published: (2020)

Sesame Oil-Based Nanostructured Lipid Carriers of Nicergoline, Intranasal Delivery System for Brain Targeting of Synergistic Cerebrovascular Protection
by: Mohammed A. S. Abourehab, et al.
Published: (2021)

Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats
by: Saud Bawazeer, et al.
Published: (2020)

Development and optimization of a tamsulosin nanostructured lipid carrier loaded with saw palmetto oil and pumpkin seed oil for treatment of benign prostatic hyperplasia
by: Rana B. Bakhaidar, et al.
Published: (2022)

Spectroscopic and molecular docking studies for characterizing binding mechanism and conformational changes of human serum albumin upon interaction with Telmisartan
by: Mohammed Al bratty
Published: (2020)

Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells
by: Ibrahim A. Aljuffali, et al.
Published: (2023)

Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)
by: M Tiseo, et al.
Published: (2010)

Improved Photocatalytic and Antioxidant Activity of Olive Fruit Extract-Mediated ZnO Nanoparticles
by: Sadia Ghaffar, et al.
Published: (2023)

Darifenacin Hydrobromide loaded nanostructured lipid carrier for oral administration
by: Ali kathem Ala Allah, et al.
Published: (2018)

Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma
by: Farah Al-Sahlawi, et al.
Published: (2024)

A Fast and Validated Reversed-Phase HPLC Method for Simultaneous Determination of Simvastatin, Atorvastatin, Telmisartan and Irbesartan in Bulk Drugs and Tablet Formulations
by: Hassan A. Alhazmi, et al.
Published: (2017)

Enhancing the Oral Bioavailability of Candesartan Cilexetil Loaded Nanostructured Lipid Carriers: In Vitro Characterization and Absorption in Rats after Oral Administration
by: Walid Anwar, et al.
Published: (2020)

Mucocutaneous side effects of gefitinib
by: Ruhaila Thekkath, et al.
Published: (2021)

Mucocutaneous side effects of gefitinib
by: Ruhaila Thekkath, et al.
Published: (2021)

ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC
by: Hongbo Zhao, et al.
Published: (2018)

Comparative evaluation of propolis nanostructured lipid carriers and its crude extract for antioxidants, antimicrobial activity, and skin regeneration potential
by: Ola M. Elkhateeb, et al.
Published: (2022)

Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis
by: Pinheiro M, et al.
Published: (2016)

Busting the Breast Cancer with AstraZeneca's Gefitinib
by: S. Chemmalar, et al.
Published: (2023)

Anastrozole Loaded Nanostructured Lipid Carriers : Preparation and Evaluation
by: Alaa Abdul-Jabbar Hashim, et al.
Published: (2021)

Optimizing response to gefitinib in the treatment of non-small-cell lung cancer
by: Pietro Carotenuto, et al.
Published: (2011)

Cellular photo(geno)toxicity of gefitinib after biotransformation
by: Meryem El Ouardi, et al.
Published: (2023)

Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis
by: Khaled M. Hosny, et al.
Published: (2022)

Clinical pharmacists as medication therapy experts in diabetic clinics in Saudi Arabia - Not just a perception but a need
by: Hafiz A. Makeen
Published: (2017)

Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
by: Mohamed Haider, et al.
Published: (2020)

Design, Development, Evaluation, and In Vivo Performance of Buccal Films Embedded with Paliperidone-Loaded Nanostructured Lipid Carriers
by: Fahad Mohammed AlMulhim, et al.
Published: (2023)

Nanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study
by: Nermin E. Eleraky, et al.
Published: (2020)

Ciprofloxacin Loaded Nanostructured Lipid Carriers Incorporated into In-Situ Gels to Improve Management of Bacterial Endophthalmitis
by: Ahmed Youssef, et al.
Published: (2020)

Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats
by: Hajer AlRasheed, et al.
Published: (2022)

Comprehensive Study of Atorvastatin Nanostructured Lipid Carriers through Multivariate Conceptualization and Optimization
by: Heba A. Ghanem, et al.
Published: (2021)

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
by: Al-Keilani MS, et al.
Published: (2018)